by Mindy Klowden | Jun 8, 2022 | Behavioral Health, Blog, Latest News
While opioid use disorder and overdose deaths have received widespread attention in recent years, alcohol use disorder (a.k.a. alcoholism) has long been a hidden but deadly epidemic. Alcohol was the most prevalent drug involved in drug-related ED visits in 2021 (39.33...
by Jordana Choucair | Jun 8, 2022 | Health IT
A group of former Blue Cross Blue Shield executives have started an $107 million investment fund focused on supporting health tech startups directed by women and entrepreneurs of color. Seae Ventures secured the funding from more than 30 investors. Approximately half...
by Jordana Choucair | Jun 8, 2022 | Life Sciences
The Federal Trade Commission (FTC) announced that it will investigate the business practices of pharmacy benefit managers (PBMs) and how they influence drug prices and the pharmacy business. The FTC unanimously voted Tuesday to require the six biggest PBMs — CVS...
by Jordana Choucair | Jun 8, 2022 | Life Sciences
New research published in JAMA found that nearly half of all drugs launched in the last two years initially cost above $150,000 a year. From 2008 to 2021, launch prices for new drugs increased by 20 percent per year. In 2020-2021 alone, prices rose 11 percent per year...
by Jordana Choucair | Jun 8, 2022 | Life Sciences
The Food and Drug Administration’s (FDA) vaccine advisory panel voted to authorize Novavax’s COVID-19 vaccine for use in adults. The panel voted 21-0, with one abstention. Novavax’s two-dose vaccine was about 90 percent effective at preventing mild, moderate, and...
Recent Comments